Clinical Trials Logo

Clinical Trial Summary

To test the efficacy of a newly-commercialized formula, 40 HPV-positive women displaying chronic cervicitis, mild dysplasia or moderate dysplasia. Women in the study group took one tablet per day containing 200 mg of EGCG, 400 mcg of Folic Acid, 1 mg of Vitamin B12 and 50 mg of Hyaluronic Acid for twelve weeks. Women in the control group received no treatment.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05625308
Study type Interventional
Source Lo.Li.Pharma s.r.l
Contact
Status Completed
Phase N/A
Start date July 1, 2022
Completion date December 2, 2022

See also
  Status Clinical Trial Phase
Terminated NCT01234480 - Intended Use Study of the BD SurePath Plus™ Pap
Terminated NCT00591305 - New Therapy of Laryngeal Papilloma In Children N/A
Completed NCT00038714 - A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis Phase 2
Completed NCT00006444 - The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women N/A
Withdrawn NCT01175499 - Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive Tract N/A
Completed NCT01827423 - Squamous Cell Carcinoma Antigen Analysis at the University Hospital Ostrava N/A
Completed NCT00001603 - The Effects of Upper Airway and Digestive Tract Tumors on the Immune System N/A
Recruiting NCT05797246 - Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP) Phase 2
Completed NCT00001126 - Treatment With Cidofovir for Children With Laryngeal Papillomatosis (Warts in the Throat) Phase 1